Kiniksa Announces Commercial Availability of ARCALYST ® (rilonacept) for Recurrent Pericarditis

NEXT STORY
10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit
PREV STORY
LAVA Therapeutics Appoints Karen J. Wilson to its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apricus Biosciences to Present at the 18th Annual BIO CEO & Investor Conference

SAN DIEGO, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Immutep Enters Into Clinical Trial Collaboration and Supply Agreement With MSD

SYDNEY, Australia, March 11, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) (“Immutep” or ...

author_avatar
NASDAQ Market News

NewLink Genetics Corporation Presents Preliminary Safety Data From Randomized Phase 2 Trial of Indoximod, an IDO Pathway Inhibitor, at San Antonio Breast Cancer Symposium

AMES, Iowa and SAN ANTONIO, Dec. 10, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), ...

author_avatar
NASDAQ Market News